⚠️ Research Use Only — For in vitro research purposes only. Not for human consumption or clinical use.
PT-141 in Bali — Melanocortin Research Peptide
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist, FDA-approved as Vyleesi for hypoactive sexual desire disorder in women. BioRelix supplies research-grade PT-141 in Bali with same-day delivery.
Buy PT-141 in Bali in Bali
HPLC tested ≥98% purity · Same-day cold-chain delivery · USDT or cash on delivery
Order Now — Rp 1,600,000 / 10mg →What is PT-141 in Bali?
PT-141, also known as Bremelanotide, is a synthetic analogue of the melanocyte-stimulating hormone alpha-MSH. Unlike other melanocortin peptides, PT-141 was developed specifically as a centrally-acting compound targeting melanocortin receptors (MC1R, MC3R, MC4R) in the brain rather than peripherally. It received FDA approval in June 2019 under the brand name Vyleesi (administered as a subcutaneous autoinjector) for the treatment of acquired, generalised hypoactive sexual desire disorder (HSDD) in premenopausal women — making it one of few research peptides with direct FDA approval. Its central mechanism via MC4R distinguishes it from peripherally-acting compounds.
Research Applications & Benefits
- MC4R Agonism — PT-141 activates melanocortin-4 receptors in the hypothalamus, the primary mechanism behind its centrally-mediated research applications
- FDA-Approved Compound — Approved as Vyleesi (2019) for HSDD in premenopausal women — one of the strongest clinical evidence bases among research peptides
- Central Nervous System Activity — Unlike peripherally-acting compounds, PT-141 crosses the blood-brain barrier to act centrally via melanocortin pathways
- Melanocortin System Research — The melanocortin system regulates multiple functions including energy homeostasis, inflammation, and sexual function — PT-141 is a key research tool
- Rapid Onset — Clinical studies show PT-141 has a relatively rapid onset of action (45–90 minutes) compared to other centrally-acting peptides
- Minimal Cardiovascular Effects — Unlike early melanocortin agonists, PT-141 has a refined receptor profile with minimal cardiovascular side effects in clinical trials
Where to Buy PT-141 in Bali in Bali
BioRelix is the leading supplier of research-grade PT-141 in Bali in Bali. Every vial is third-party HPLC tested with a Certificate of Analysis (CoA) included. We deliver same-day across Canggu, Seminyak, Ubud, Kuta, Sanur, Uluwatu, and all Bali areas (orders before 2 PM WITA). Payment via USDT (TON/TRC-20) or cash on delivery — no account or ID required.
Frequently Asked Questions
What is PT-141?
PT-141 (Bremelanotide) is a synthetic melanocortin receptor agonist FDA-approved as Vyleesi. It acts centrally via MC4R in the hypothalamus. Sold by BioRelix for research use only.
Is PT-141 the same as Melanotan 2?
PT-141 was derived from Melanotan 2 but is a distinct compound. PT-141 is a metabolite of Melanotan 2 and acts via the same melanocortin receptors, but has been independently developed and FDA-approved. It lacks the tanning effects of Melanotan 2.
Is PT-141 legal in Indonesia?
PT-141 is not classified as a controlled substance by BPOM. BioRelix supplies it as a research peptide for personal research use only.
How should PT-141 be stored in Bali's climate?
Store lyophilised PT-141 at 2–8°C. Reconstituted solution should be kept refrigerated and used within 28 days. BioRelix delivers with cold-chain ice packs.
Does BioRelix deliver PT-141 same day?
Yes — orders placed before 2 PM WITA are delivered same day across Canggu, Seminyak, Ubud, Kuta, and all Bali areas.
Order PT-141 in Bali in Bali
Rp 1,600,000 / 10mg · Includes bacteriostatic water, syringes, alcohol swabs & reconstitution guide
Order via BioRelix →⚠️ Reminder: For research use only. Not for human consumption. Consult a licensed physician for medical advice.